Evidence map›Paper›PMID 35309454›Full record

ArticleACS omega2022

ROS-Scavenging Selenofluoxetine Derivatives Inhibit

Giovanni Ribaudo, Marco Bortoli, Colby E Witt, Brenna Parke, Sergio Mena, Erika Oselladore, Giuseppe Zagotto, Parastoo Hashemi, Laura Orian

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Microdosing ketamine inbioRxiv : the preprint server for biology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Giovanni RibaudoDipartimento di Medicina Molecolare e Traslazionale, Università degli Studi di Brescia, Viale Europa 11, 25123 Brescia, Italy.ORCID https://orcid.org/0000-0003-3679-5530
Marco BortoliDipartimento di Scienze Chimiche, Università degli Studi di Padova Via Marzolo 1, 35131 Padova, Italy.ORCID https://orcid.org/0000-0001-5506-6347
Colby E WittDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia South Carolina 29201, United States.
Brenna ParkeDepartment of Bioengineering, Imperial College London, London SW7 2AZ, U.K.
Sergio MenaDepartment of Bioengineering, Imperial College London, London SW7 2AZ, U.K.
Erika OselladoreDipartimento di Medicina Molecolare e Traslazionale, Università degli Studi di Brescia, Viale Europa 11, 25123 Brescia, Italy.
Giuseppe ZagottoDipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via Marzolo 5, 35131 Padova, Italy.ORCID https://orcid.org/0000-0001-7053-4196
Parastoo HashemiDepartment of Bioengineering, Imperial College London, London SW7 2AZ, U.K.ORCID https://orcid.org/0000-0002-0180-767X
Laura OrianDipartimento di Scienze Chimiche, Università degli Studi di Padova Via Marzolo 1, 35131 Padova, Italy.ORCID https://orcid.org/0000-0002-1673-5111
University of Padua · ITImperial College London · GBUniversity of Brescia · ITUniversity of South Carolina · US

Funding

An In Vivo Voltammetric Serotonin Biomarker for Antidepressant EfficacyR01MH106563 · NIMH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HASHEMI, PARASTOO · 2016 to 2020
$1.6M
NIMH NIH HHS R01 MH106563
6 · The paper itself

Abstract

While the neurochemistry that underpins the behavioral phenotypes of depression is the subject of many studies, oxidative stress caused by the inflammation comorbid with depression has not adequately been addressed. In this study, we described novel antidepressant-antioxidant agents consisting of selenium-modified fluoxetine derivatives to simultaneously target serotonin reuptake (antidepressant action) and oxidative stress. Excitingly, we show that one of these agents (

Identifiers

PMID35309454
PMCPMC8928538
OpenAlexW4220865981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.